Methods for treating congestive heart failure

US10232016B2 · kind B2 · utility

Assignees

• Acorda Therapeutics, Inc. · US
• Beth Israel Deaconess Medical Center, Inc. · US
• The Brigham and Women's Hospital, Inc. · US

Inventors

• Mark Marchionni · Arlington, US
• Ralph Kelly · Catoosa, US
• Beverly Lorell · Needham, US
• Douglas B. Sawyer · Brookline, US

Key dates

• Filing date: Sep 3, 2015
• Grant date: Mar 19, 2019
• Expiry date: Apr 8, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.